Monopar Therapeutics Inc
(MNPR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,516 | -5,079 | -2,625 | -15,586 | -4,661 |
| Other Working Capital | -1,049 | -1,297 | -1,393 | 489 | -607 |
| Other Operating Activity | 734 | -365 | -1,645 | 8,693 | 862 |
| Operating Cash Flow | $-8,831 | $-6,741 | $-5,663 | $-6,404 | $-4,406 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -1,265 | 862 | -326 | -14,338 | 0 |
| Investing Cash Flow | $-1,265 | $862 | $-326 | $-14,338 | $0 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 127,793 | 20 | 15 | 59,396 | 3,193 |
| Common Stock Repurchased | -35,000 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -834 | -453 | -131 | -104 | -37 |
| Financing Cash Flow | $91,959 | $-433 | $-116 | $59,292 | $3,155 |
| Exchange Rate Effect | -2 | -3 | 0 | 1 | 4 |
| Beginning Cash Position | 45,816 | 45,816 | 45,816 | 7,266 | 7,266 |
| End Cash Position | 127,677 | 39,502 | 39,711 | 45,816 | 6,020 |
| Net Cash Flow | $81,861 | $-6,314 | $-6,105 | $38,550 | $-1,246 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,831 | -6,741 | -5,663 | -6,404 | -4,406 |
| Free Cash Flow | -8,831 | -6,741 | -5,663 | -6,404 | -4,406 |